Lessons learned from next-generation sequencing in head and neck cancer - PubMed (original) (raw)

Review

Lessons learned from next-generation sequencing in head and neck cancer

Myriam Loyo et al. Head Neck. 2013 Mar.

Abstract

Scientific innovation has enabled whole exome capture and massively parallel sequencing of cancer genomes. In head and neck cancer, next-generation sequencing has granted us further understanding of the mutational spectrum of squamous cell carcinoma. As a result of these new technologies, frequently occurring mutations were identified in NOTCH1, a gene that had not previously been implicated in head and neck cancer. The current review describes the most common mutations in head and neck cancer: TP53, NOTCH1, HRAS, PIK3CA, and CDKN2A. Emphasis is placed on the involved cellular pathways, clinical correlations, and potential therapeutic interventions. Additionally, the implications of human papillomavirus on mutation patterns are discussed.

PubMed Disclaimer

Cited by

Noncanonical Cell Death Induction by Reassortant Reovirus.
Rodríguez Stewart RM, Raghuram V, Berry JTL, Joshi GN, Mainou BA. Rodríguez Stewart RM, et al. J Virol. 2020 Oct 27;94(22):e01613-20. doi: 10.1128/JVI.01613-20. Print 2020 Oct 27. J Virol. 2020. PMID: 32847857 Free PMC article.
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Trigo J, et al. Clin Transl Oncol. 2022 Oct;24(10):1890-1902. doi: 10.1007/s12094-022-02856-1. Epub 2022 Jun 23. Clin Transl Oncol. 2022. PMID: 35739348 Free PMC article.
Unraveling the molecular genetics of head and neck cancer through genome-wide approaches.
Riaz N, Morris LG, Lee W, Chan TA. Riaz N, et al. Genes Dis. 2014 Sep;1(1):75-86. doi: 10.1016/j.gendis.2014.07.002. Genes Dis. 2014. PMID: 25642447 Free PMC article.
CTEN Induces Tumour Cell Invasion and Survival and Is Prognostic in Radiotherapy-Treated Head and Neck Cancer.
Fleming JC, Woo J, Moutasim K, Hanley CJ, Frampton SJ, Wood O, Ward M, Woelk CH, Ottensmeier CH, Hafizi S, Kim D, Thomas GJ. Fleming JC, et al. Cancers (Basel). 2020 Oct 13;12(10):2963. doi: 10.3390/cancers12102963. Cancers (Basel). 2020. PMID: 33066224 Free PMC article.
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer.
Bommireddy R, Munoz LE, Kumari A, Huang L, Fan Y, Monterroza L, Pack CD, Ramachandiran S, Reddy SJC, Kim J, Chen ZG, Saba NF, Shin DM, Selvaraj P. Bommireddy R, et al. Vaccines (Basel). 2020 Apr 14;8(2):182. doi: 10.3390/vaccines8020182. Vaccines (Basel). 2020. PMID: 32295135 Free PMC article.

References

1. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359:1143–1154. - PubMed
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
1. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9–22. - PubMed
1. Agrawal N, Frederick MJ, Pickering CR, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154–1157. - PMC - PubMed
1. Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333:1157–1160. - PMC - PubMed

Lessons learned from next-generation sequencing in head and neck cancer - PubMed (original) (raw)